The Korean Journal of Blood Transfusion : eISSN 2383-6881 / pISSN 1226-9336

Table. 2.

Table. 2.

Alloantibodies detected in patients with hematologic diseases

No. Age Sex Ab. Dis. Period between Ab detection and last transfusion RBC episodes RBC volume (unit)
1 60 F E LYM 1213 days 26 47.6
2 58 F E MM 259 days 6 9.6
3 54 M Jk(a) CMML 5 days 17 42
4 69 M E MDS 26 days 70 128.8
5 74 M E, c, Le(a) MDS 8 days 15 21.6
6 49 F unid CML 18 days 5 9.4
7 72 F C, Jk(a), Le(a) LYM 5 days 18 32.2
8 71 M unid ET 9 days 7 8.8
9 57 M unid LYM 232 days 24 46.8
10 41 F E MDS 30 days 41 91
11 49 M E APL 209 days 10 19.8
12 58 F E, unid APL 640 days 26 48.8
13 73 M C, Kp(a) MDS 5 days 59 112.6
14 71 M C, e MDS 84 days 91 128
15 65 F E, unid ITP 2121 days 8 22.4
16 46 F E, unid AML 159 days 10 16
17 63 M E AA 7 days 12 25
18 71 F E, c, unid AA 45 days 23 43

1 unit is 400 mL of RBCs, FFP, PLTs.

Abbreviations: Ab, alloantibodies; Dis, disease; Episodes, the number of RBC transfusion episodes; Volume, RBC transfusion volume; LYM, lymphoma; Unid, unidentified antibodies; ET, essential thrombocythemia; APL, acute promyelocytic leukemia.

Korean J Blood Transfus 2022;33:14-23 https://doi.org/10.17945/kjbt.2022.33.1.14
© 2022 Korean J Blood Transfus